Prescription Opioid Misuse Assessment
CompletedNCT03195374
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Chronic pain is a worldwide health problem due to its high prevalence and its difficult management with a significant impact on quality of life. Pain and addiction co-occur frequently. Indeed, the prevalence of addiction in patients with chronic non-cancer pain may affect from 0% to 50% of patients (Højsted et al 2010). This large variability in the estimation of addiction prevalence in chronic non-cancer pain patients is at least partly due to a lack of standardization of the selected patients from the clinical or therapeutic point of view and the lack of consensus in the use of a specific evaluation tool or gold standard. Indeed, several tools are currently available at the international level with varying efficiencies and precisions (Chou et al 2009, Turk, Swanson, and Gatchel 2008, Højsted and Sjøgren 2007). In France, no data are available on the prevalence of analgesic opioid misuse in chronic non-cancer pain patients, due to the lack clinical studies and validated tools in French.
Study details
- Official title
- Assessment of the Prevalence of Analgesics Opioid Misuse in Chronic Non-cancer Pain Patients
- Conditions
- Interventions
- Other: Prescription Opioid Misus Index
- Sponsor
- University Hospital, Clermont-Ferrand
- Collaborators
- CEIP-A Lyon; CEIP-A Marseille; CEIP-A Caen; CEIP-A Lille; CEIP-A Montpellier; CEIP-A Nantes; CEIP-A Poitiers; CEIP-A Toulouse; CEIP-A Bordeaux
- Start date
- 2018-08-24
- Primary completion
- 2019-07-09
- Sex
- All
- Age range
- from 18 Years to 100 Years
- Results posted
- No results posted in this snapshot
- Countries
- France
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients (male or female) ≥ 18 years old * Patients with chronic non-cancer pain for at least 6 months * Patients treated with analgesic opioids for at least 3 months Exclusion Criteria: * Patients (male or female) \< 18 years old * Patients with chronic pain for less than 6 months * Patients with cancer pain * Patients treated with analgesic opioids for less than 3 months
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03195374